PHIO PHIO

Phio Pharmaceuticals Stock Price

1.63
-0.08 (-4.68%)
1.63
Volume 181,730
Bid Price 1.63
Ask Price 1.64
News -
Day High 1.69

Low
1.57

52 Week Range

High
4.36

Day Low 1.61
Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Phio Pharmaceuticals Corporation PHIO NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.08 -4.68% 1.63 17:20:41
Open Price Low Price High Price Close Price Prev Close
1.68 1.61 1.69 1.63 1.71
Trades Volume VWAP Dollar Volume Avg Volume 52 Week Range
549 181,730 $ 1.65 $ 300,157 - 1.57 - 4.36
Last Trade Time Type Quantity Stock Price Currency
17:12:33 43 $ 1.63 USD

Period:

Draw Mode:

Phio Pharmaceuticals Corporation Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
$ 22.06M 13.53M 13.50M $ - $ - -2.48 -1.30
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - - - 10.50%

more financials information »

Phio Pharmaceuticals News

Loading Messages....

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical PHIO Price Data

Period Open High Low VWAP Avg. Daily Vol Change %
1 Week1.661.811.611.69225,250-0.03-1.81%
1 Month2.152.191.591.80220,891-0.52-24.19%
3 Months1.822.401.572.03465,975-0.19-10.44%
6 Months2.382.851.572.25650,116-0.75-31.51%
1 Year2.174.361.572.73791,355-0.54-24.88%
3 Years0.3910.850.0971.83712,5271.24317.95%
5 Years0.3910.850.0971.83712,5271.24317.95%

Phio Pharmaceuticals Description

Phio Pharmaceuticals Corp is a US-based biotechnology company. It is principally engaged in developing immuno-oncology therapeutics based on its proprietary self-delivering RNAi platform and Samcyprone, a topical immunomodulator, which addresses significant unmet medical needs. The company's pipeline products include PH-762, PH-804, PH-790, and others.
Your Recent History
NASDAQ
PHIO
Phio Pharm..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20211022 23:03:26